Corona Remedies Limited IPO

Corona Remedies Limited is listed in the MAINBOARD segment with a price band of ₹1,008 to ₹1,062. The figures below are as reported by the exchanges and public sources.

Corona Remedies Limited IPO — key facts

• The Corona Remedies Limited IPO price band is ₹1,008 to ₹1,062 per share.
• As of 5 September 2026, the Corona Remedies Limited IPO subscription status is 144.54x overall.
• The issue is open from 08-DEC-2025 to 10-DEC-2025.
• Corona Remedies Limited listed on 15-DEC-2025.
• Corona Remedies Limited listed at ₹1,437.2. The listing gain was 35.3% against the upper end of the issue price band.

Corona Remedies Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹1,008 – ₹1,062

Issue size

₹655.37 Cr

Offer for sale

₹655.37 Cr

Opens

08-DEC-2025

Closes

10-DEC-2025

Listing

15-DEC-2025

Total subscription

144.54x

Retail

30.39x

QIB

293.80x

NII

220.18x

Lead managers

JM Financial (left lead)

Listing price

₹1,437.2

Listing day change

+35.3%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.